Based on the Create Medic Co Ltd stock forecast from 0 analysts, the average analyst target price for Create Medic Co Ltd is not available over the next 12 months. Create Medic Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Create Medic Co Ltd is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Create Medic Co Ltd’s stock price was JPY 906.00. Create Medic Co Ltd’s stock price has changed by -0.55% over the past week, -0.11% over the past month and -1.20% over the last year.
No recent analyst target price found for Create Medic Co Ltd
No recent average analyst rating found for Create Medic Co Ltd
Company Overview Create Medic Co Ltd
Create Medic Co., Ltd. engages in the research, manufacture, and sale of medical appliances in Japan and internationally. The company offers urology products, including all silicone foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as all silicone malecot and self-catheters for replacement, pure-cath, nephrostomy kits, and cystostomy and self-catheterization sets; and gastroenterology products, all silicone Ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube sets. It also provides all silicone gastrostomy balloon catheters, various types of PEG kits, loop fixtures, balloon and gastrostomy button sets, gastrostomy replacement catheter sets, all silicone PEG J catheters, and transgastric jejunal balloon tube and guidewire sets. In addition, the company offers surgery products comprising PTC drainage tubes, PTCD kits, cholangio-entero tubes, and internal external drainage catheter for PTCD; and other products, such as all silicone endotracheal and tracheostomy tubes, and micro catheters. Further, it provides OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan. Read Less
Create Medic Co., Ltd. engages in the research, manufacture, and sale of medical appliances in Japan and internationally. The company offers urology products, including all silicone foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as all silicone m...Read More
Frequently Asked Questions About Create Medic Co Ltd (5187:TSE) Stock
Stock Target Advisor's fundamental analysis for Create Medic Co Ltd's stock is Neutral.
5187:TSE stock's dividend yield is 4.09%.
Our analysis grades 5187:TSE stock's dividend yield at F. This means that 5187:TSE stock's dividend yield is above 46% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 5187:TSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 5187:TSE's stock to indicate what its average analyst target is.
5187:TSE stock's Price/Earning ratio is 20.79.
Our analysis grades 5187:TSE stock's Price / Earning ratio at F. This means that 5187:TSE stock's Price/Earning ratio is above 53% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 5187:TSE may be a overvalued for its sector.
The last closing price of 5187:TSE's stock was JPY 906.00.
The most recent market capitalization for 5187:TSE is JPY 7.80B.
Unfortunately we do not have enough analyst data on 5187:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Create Medic Co Ltd's stock.
As per our most recent records Create Medic Co Ltd has 962 Employees.
Create Medic Co Ltd's registered address is 2-5-25 Chigasakiminami, Yokohama, Japan, 224-0037.
You can get more information about it from Create Medic Co Ltd's website at https://www.createmedic.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Create Medic Co Ltd (5187:TSE) Stock
Stock Target Advisor's fundamental analysis for Create Medic Co Ltd's stock is Neutral.
5187:TSE stock's dividend yield is 4.09%.
Our analysis grades 5187:TSE stock's dividend yield at F. This means that 5187:TSE stock's dividend yield is above 46% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 5187:TSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 5187:TSE's stock to indicate what its average analyst target is.
5187:TSE stock's Price/Earning ratio is 20.79.
Our analysis grades 5187:TSE stock's Price / Earning ratio at F. This means that 5187:TSE stock's Price/Earning ratio is above 53% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 5187:TSE may be a overvalued for its sector.
The last closing price of 5187:TSE's stock was JPY 906.00.
The most recent market capitalization for 5187:TSE is JPY 7.80B.
Unfortunately we do not have enough analyst data on 5187:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Create Medic Co Ltd's stock.
As per our most recent records Create Medic Co Ltd has 962 Employees.
Create Medic Co Ltd's registered address is 2-5-25 Chigasakiminami, Yokohama, Japan, 224-0037.
You can get more information about it from Create Medic Co Ltd's website at https://www.createmedic.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 5187:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
